- Title
- Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 Carriers
- Creator
- Kiljanczyk, Adam; Matuszczak, Milena; Huzarski, Tomasz; Lener, Marcin R.; Jakubowska, Anna; Cheriyan, Angela; Szwiec, Marek; Stawicka-Nielacna, Malgorzata; Godlewski, Dariusz; Prusaczyk, Artur; Jasiewicz, Andrzej; Kluz, Tomasz; Marciniak, Wojciech; Tomiczek-Szwiec, Joanna; Kilar-Kobierzycka, E; Siolek, M; Wisniowski, R; Posmyk, R; Jarkiewicz-Tretyn, J; Sun, P; Scott, Rodney J.; Narod, SA; Lubinski, J; Derkacz, Roza; Stempa, Klaudia; Baszuk, Piotr; Bryskiewicz, Marta; Cybulski, Cezary; Debniak, Tadeusz; Gronwald, Jacek
- Relation
- Nutrients Vol. 16, Issue 11, no. 1788
- Publisher Link
- http://dx.doi.org/10.3390/nu16111788
- Publisher
- MDPI AG
- Resource Type
- journal article
- Date
- 2024
- Description
- Breast cancer and ovarian cancer pose a significant risk for BRCA1 carriers, with limited risk-reduction strategies. While improved screening helps in the early detection of breast cancer, preventive measures remain elusive. Emerging evidence suggests a potential link between iodine levels and modulation of cancer risk, but comprehensive studies are scarce. We conducted a prospective study among 989 BRCA1 carriers to assess the association between blood iodine levels and breast and ovarian cancer risk. Using inductively coupled plasma mass spectrometry, we measured blood iodine levels and observed a negative association with breast cancer risk, with a significantly lower risk observed in quartile 4 (iodine > 38.0 µg/L) compared with quartile 1 (iodine < 30 µg/L) (HR = 0.49; 95%CI: 0.27–0.87; p = 0.01). Conversely, a suggestive increase in ovarian cancer risk was observed at higher iodine levels (HR = 1.91; 95%CI: 0.64–5.67; p = 0.25). No significant association was found between iodine levels and overall cancer risk. Our results suggest the potential of iodine to reduce breast cancer risk in BRCA1 carriers after prophylactic oophorectomy but require further validation and investigation of its effect on ovarian cancer risk and overall mortality. These findings highlight the need for personalized strategies to manage cancer risk in BRCA1 carriers.
- Subject
- microelements; cancer; BRCA1; breast cancer; ovarian cancer; nutrients; SDG 3; Sustainable Development Goal
- Identifier
- http://hdl.handle.net/1959.13/1517366
- Identifier
- uon:57078
- Identifier
- ISSN:2072-6643
- Rights
- x
- Language
- eng
- Reviewed
- Hits: 103
- Visitors: 98
- Downloads: 0